5-HT2ASNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics
Carolina Digital Repository (University of North Carolina at Chapel Hill) · 10.05.2024
DOI: 10.17615/6vws-y535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carolina Digital Repository (University of North Carolina at Chapel Hill), erschienen am 10.05.2024. Verfasst von Samuel T. Slocum und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Serotonin (5-hydroxytryptamine; 5-HT) 2A receptor (5-HT2AR) signaling is essential for the actions of classical psychedelic drugs. In this study, we examined whether sequence variations in the 5-HT2AR gene affect the signaling of four commonly used psychedelic drugs. We examined the in vitro pharmacology of seven non-synonymous single-nucleotide polymorphisms (SNPs), which give rise to Ser12Asn, Thr25Asn, Asp48Asn, Ile197Val4.47, Ala230Thr, Ala447Val, and His452Tyr variant 5-HT2A serotonin receptors. We found that these non-synonymous SNPs exert statistically significant, although modest, effects on the efficacy and potency of four therapeutically relevant psychedelics. Significantly, the in vitro pharmacological effects of the SNP drug actions at 5-HT2AR are drug specific.
Schlagwörter
Zitieren
APA
Slocum, S. T., Roth, B. L., G.P, S., & M.K, J. (2024). 5-HT2ASNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/6vws-y535
Vancouver
Slocum ST, Roth BL, G.P S, M.K J. 5-HT2ASNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics. Carolina Digital Repository (University of North Carolina at Chapel Hill). 2024. doi:10.17615/6vws-y535
BibTeX
@article{Slocum2024,
author = {Slocum, Samuel T. and Roth, Bryan L. and G.P, Schmitz and M.K, Jain},
title = {5-HT2ASNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics},
journal = {Carolina Digital Repository (University of North Carolina at Chapel Hill)},
year = {2024},
doi = {10.17615/6vws-y535}
}
EUVIMED